This ETF Holds Stocks Insiders Want to Own

A seem at the weighted underlying holdings of the SPDR S&P Biotech ETF (XBI) shows ~y impressive 14.2% of holdings in successi~ a weighted basis have experienced insider buying in the compass of the past six months.

Click to this place to find out 10 ETFs With Stocks That Insiders Are Buying »

Amicus Therapeutics Inc (NASD: FOLD), that makes up 1.23% of the SPDR S&P Biotech ETF (XBI), has seen 8 directors and officers possession shares in the past six months, according to the latter Form 4 data. The ETF holds a integral of $24,021,798 worth of FOLD, workmanship it the #7 largest holding. The index below details the recent insider buying mode of action observed at FOLD:

FOLD — final trade: $10.28 — Recent Insider Buys:

Purchased

Insider

Title

Shares

Price/Share

Value

11/19/2014

Advisors Llc Perceptive

2,100,000

$6.50

$13,650,000

11/25/2014

Ken Valenzano

VP, Pharmacology & Biology

25,000

$8.00

$200,000

11/25/2014

Daphne Quimi

VP Finance and Controller

3,500

$8.00

$28,000

11/25/2014

Kenneth Peist

VP, Legal & IP

4,500

$8.00

$36,000

11/25/2014

Enrique Dilone

VP, Technical Operations

7,000

$8.00

$56,000

11/25/2014

Jeff Castelli

VP, Program Management

8,103

$8.00

$64,824

11/25/2014

Bradley L. Campbell

Chief Operating Officer

7,250

$8.00

$58,000

11/25/2014

William D. Baird III

Chief Financial Officer

10,000

$8.00

$80,000

12/04/2014

John F. Crowley

Chairman & CEO

89,000

$8.36

$743,906

And Chimerix Inc. (NASD: CMRX), the #71 largest holding amid components of the SPDR S&P Biotech ETF (XBI), shows 2 directors and officers viewed like recently filing Form 4′s indicating purchases. The ETF holds $18,202,793 ~iness of CMRX, which represents approximately 0.93% of the ETF’s ~ity assets at last check. The recent insider buying activity observed at CMRX is detailed in the even below:

CMRX — last trade: $34.91 — Recent Insider Buys:

Purchased

Insider

Title

Shares

Price/Share

Value

11/05/2014

Ernest Mario

Director

10,000

$29.00

$290,000

11/05/2014

John M. Leonard

Director

4,000

$29.00

$116,000

Special Offer: Join the income investing conversation on ValueForum.com by a special Seven Days for Seven Dollars bidding from Forbes.

But I have not mould many economists capable of such eccentric person thinking, even among those who claim to support the progressive banner.

Recent Comments

    Archives